why choose us

First received: June 24, 2024

Clinical Trial: Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Polycystic Ovary Syndrome

Study Type: INTERVENTIONAL


Official Title: Association of Serum Biomarkers in Polycystic Ovarian Syndrome (PCOS) Females With and Without Metformin Versus Healthy Controls

Brief Summary: The goal of this interventional study is to assess the effect of drug metformin in improving the fertility hormones and reducing the inflammatory hormones in polycystic ovarian syndrome (PCOS) patients.We wish to answer the question whether metformin is necessary to improve PCOS symptoms versus simple lifestyle modification.Participants once diagnosed with PCOS will be given metformin to be sued for 8 weeks.They will be asked to provide blood samples on day 0 and after 8 weeks of metformin use.The blood sample…

Read more